Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

PubWeight™: 3.87‹?› | Rank: Top 1%

🔗 View Article (PMC 2593146)

Published in Am J Kidney Dis on June 30, 2008

Authors

Manjula Kurella Tamura1, Virginia Wadley, Kristine Yaffe, Leslie A McClure, George Howard, Rodney Go, Richard M Allman, David G Warnock, William McClellan

Author Affiliations

1: Department of Medicine, University of California San Francisco, San Francisco, CA, USA. manjula.tamura@ucsf.edu

Articles citing this

(truncated to the top 100)

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06

Kidney function is associated with the rate of cognitive decline in the elderly. Neurology (2009) 2.27

Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc (2010) 2.03

Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders. Am J Kidney Dis (2008) 1.91

Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006. Hypertension (2009) 1.88

Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol (2011) 1.77

Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant (2009) 1.71

Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71

Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65

Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin J Am Soc Nephrol (2011) 1.62

CKD associates with cognitive decline. J Am Soc Nephrol (2009) 1.55

Fine particulate matter and incident cognitive impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. PLoS One (2013) 1.53

Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology (2011) 1.49

Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int (2010) 1.47

Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis (2010) 1.44

Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int (2011) 1.43

Renal function and long-term decline in cognitive function: the Baltimore Longitudinal Study of Aging. Am J Nephrol (2015) 1.40

Cardiovascular disease and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis (2011) 1.35

Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol (2010) 1.32

Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis (2011) 1.31

Patient perspectives on informed decision-making surrounding dialysis initiation. Nephrol Dial Transplant (2013) 1.30

Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality. Clin J Am Soc Nephrol (2011) 1.26

Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2010) 1.15

Impact of chronic kidney disease on activities of daily living in community-dwelling older adults. J Gerontol A Biol Sci Med Sci (2011) 1.11

Cognitive impairment in CKD: no longer an occult burden. Am J Kidney Dis (2010) 1.11

Clinical Interaction between Brain and Kidney in Small Vessel Disease. Cardiol Res Pract (2011) 1.10

Association of CKD with disability in the United States. Am J Kidney Dis (2010) 1.10

Low income and albuminuria among REGARDS (Reasons for Geographic and Racial Differences in Stroke) study participants. Am J Kidney Dis (2012) 1.09

Neuropsychiatric complications of chronic kidney disease. Nat Rev Nephrol (2010) 1.08

Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis (2009) 1.06

Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory. Nephrol Dial Transplant (2012) 1.06

Lower socioeconomic status and disability among US adults with chronic kidney disease, 1999-2008. Prev Chronic Dis (2011) 1.04

The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients. Am J Kidney Dis (2012) 1.04

Patient and facility safety in hemodialysis: opportunities and strategies to develop a culture of safety. Clin J Am Soc Nephrol (2012) 1.02

Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology (2013) 1.02

Nondisease-specific problems and all-cause mortality among older adults with CKD: the REGARDS Study. Clin J Am Soc Nephrol (2014) 1.01

Aging and chronic kidney disease: the impact on physical function and cognition. J Gerontol A Biol Sci Med Sci (2013) 1.01

Cognitive profile of chronic kidney disease and hemodialysis patients without dementia. Nephron Clin Pract (2010) 1.01

Frailty and Cognitive Function in Incident Hemodialysis Patients. Clin J Am Soc Nephrol (2015) 1.00

Associations of dietary fat with albuminuria and kidney dysfunction. Am J Clin Nutr (2010) 0.99

Contrasting Cholesterol Management Guidelines for Adults with CKD. J Am Soc Nephrol (2014) 0.98

Association between renal function and cognitive ability domains in the Einstein aging study: a cross-sectional analysis. J Gerontol A Biol Sci Med Sci (2014) 0.97

Kidney disease and cognitive function. Contrib Nephrol (2013) 0.93

The association of statin use and statin type and cognitive performance: analysis of the reasons for geographic and racial differences in stroke (REGARDS) study. Clin Cardiol (2010) 0.92

The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One (2014) 0.92

Chronic kidney disease in octogenarians. Clin J Am Soc Nephrol (2011) 0.92

Report of stroke-like symptoms predicts incident cognitive impairment in a stroke-free cohort. Neurology (2013) 0.92

Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Clin Nutr (2011) 0.92

The cognition-kidney disease connection: lessons from population-based studies in the United States. Am J Kidney Dis (2008) 0.91

Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2014) 0.89

Cerebral small vessel disease and chronic kidney disease. J Stroke (2015) 0.89

Cognitive function and the risk of death in chronic kidney disease. Am J Nephrol (2011) 0.88

Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol (2012) 0.88

Status of vitamins B-12 and B-6 but not of folate, homocysteine, and the methylenetetrahydrofolate reductase C677T polymorphism are associated with impaired cognition and depression in adults. J Nutr (2012) 0.87

Duration of chronic kidney disease reduces attention and executive function in pediatric patients. Kidney Int (2014) 0.87

Mid-life proteinuria and late-life cognitive function and dementia in elderly men: the Honolulu-Asia Aging Study. Alzheimer Dis Assoc Disord (2015) 0.87

The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old. Arch Med Sci (2016) 0.86

Kidney function and cognitive health in older adults: the Cardiovascular Health Study. Am J Epidemiol (2014) 0.86

Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation. J Diabetes Investig (2014) 0.86

Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens (2012) 0.86

Association of chronic kidney disease and cerebral small vessel disease with cognitive impairment in elderly patients with type 2 diabetes. Dement Geriatr Cogn Dis Extra (2013) 0.85

Relationship between longitudinal measures of renal function and onset of dementia in a community cohort of older adults. J Am Geriatr Soc (2012) 0.84

Hemoglobin concentration and cognitive impairment in the renal REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. J Gerontol A Biol Sci Med Sci (2010) 0.83

Kidney disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther (2015) 0.83

Chronic kidney disease in primary care: an opportunity for generalists. J Gen Intern Med (2011) 0.82

Cardiorenal metabolic syndrome and diabetic cognopathy. Cardiorenal Med (2013) 0.82

Diagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate. Aging Dis (2012) 0.81

Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc (2014) 0.81

Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta (2016) 0.80

Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol (2011) 0.80

Relationship between total testosterone, cognitive function, depressive behavior, and sleep quality in chronic kidney disease patients not on dialysis. Clin Exp Nephrol (2012) 0.80

The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function. Am J Kidney Dis (2015) 0.79

Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND. Nephrol Dial Transplant (2015) 0.79

Role of lean body mass in estimating glomerular filtration rate in Alzheimer disease. Nephrol Dial Transplant (2010) 0.78

Anemia and risk for cognitive decline in chronic kidney disease. BMC Nephrol (2016) 0.78

Neurological complications in chronic kidney disease. JRSM Cardiovasc Dis (2016) 0.77

Cognitive impairment and depression in a population of patients with chronic kidney disease in Colombia: a prevalence study. Can J Kidney Health Dis (2016) 0.77

Low income, community poverty and risk of end stage renal disease. BMC Nephrol (2014) 0.77

Role of Vitamin D in Cognitive Function in Chronic Kidney Disease. Nutrients (2016) 0.76

Cognitive Impairment and Progression of CKD. Am J Kidney Dis (2016) 0.76

Age, eGFR, and CKD complications. Clin J Am Soc Nephrol (2011) 0.75

Polyclonal light chains in cerebrovascular disease. Neuropsychiatr Dis Treat (2010) 0.75

Abdominal obesity is a risk factor for dysexecutive function in chronic kidney disease. Prev Med Rep (2016) 0.75

Consequences of CKD on Functioning. Semin Nephrol (2016) 0.75

Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals. J Acquir Immune Defic Syndr (2014) 0.75

Ocular fundus pathology and chronic kidney disease in a Chinese population. BMC Nephrol (2011) 0.75

Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise. Biomed Res Int (2017) 0.75

Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy. Medicine (Baltimore) (2016) 0.75

Cognitive dysfunction and depression in adult kidney transplant recipients: baseline findings from the FAVORIT Ancillary Cognitive Trial (FACT). J Ren Nutr (2011) 0.75

Cognitive Impairment and Dementia in Older Adults With Chronic Kidney Disease: A Review. Alzheimer Dis Assoc Disord (2016) 0.75

Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study. PLoS One (2015) 0.75

Captain Lord's uremia. Turk J Urol (2013) 0.75

Severe Decline of Estimated Glomerular Filtration Rate Associates with Progressive Cognitive Deterioration in the Elderly: A Community-Based Cohort Study. Sci Rep (2017) 0.75

Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2017) 0.75

Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis (2017) 0.75

Cognitive function and advanced kidney disease: longitudinal trends and impact on decision-making. Clin Kidney J (2017) 0.75

[Assisted peritoneal dialysis: home-based renal replacement therapy for the elderly patient]. Wien Med Wochenschr (2013) 0.75

Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study. J Alzheimers Dis (2016) 0.75

An association of cognitive impairment with diabetes and retinopathy in end stage renal disease patients under peritoneal dialysis. PLoS One (2017) 0.75

Articles cited by this

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med (1999) 82.86

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol (1989) 37.83

The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33

Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27

Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20

Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care (2002) 8.22

Midlife cardiovascular risk factors and risk of dementia in late life. Neurology (2005) 5.12

Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology (2001) 4.78

Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology (2003) 3.99

Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14

Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol (2004) 2.82

Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med (2006) 2.58

Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol (2007) 2.01

Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis (2005) 1.91

Articles by these authors

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02

Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57

Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med (2011) 8.54

The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol (2011) 8.15

Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA (2005) 6.20

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69

Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin. Am J Cardiol (2011) 5.46

Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA (2003) 5.23

The NIH Cognitive and Emotional Health Project. Report of the Critical Evaluation Study Committee. Alzheimers Dement (2006) 5.05

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke (2006) 5.04

Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61

Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J (2006) 4.55

Hearing loss and cognitive decline in older adults. JAMA Intern Med (2013) 4.25

A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum (2012) 4.01

Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol (2008) 3.63

Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry (2006) 3.61

Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2007) 3.61

A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study. J Am Geriatr Soc (2009) 3.58

Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52

Limited literacy and mortality in the elderly: the health, aging, and body composition study. J Gen Intern Med (2006) 3.51

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 3.50

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46

Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation (2005) 3.38

Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. Ann Intern Med (2006) 3.38

Measuring life-space mobility in community-dwelling older adults. J Am Geriatr Soc (2003) 3.31

Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22

Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA (2002) 3.16

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14

Patient and caregiver characteristics associated with depression in caregivers of patients with dementia. J Gen Intern Med (2003) 3.13

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11

A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults. J Am Geriatr Soc (2003) 3.09

Association of race and sex with risk of incident acute coronary heart disease events. JAMA (2012) 3.07

Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06

Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol (2002) 3.04

Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med (2008) 2.99

Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med (2003) 2.94

The association between physical function and lifestyle activity and exercise in the health, aging and body composition study. J Am Geriatr Soc (2004) 2.93

Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke (2013) 2.88

Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort. Hypertension (2013) 2.83

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch Intern Med (2009) 2.82

Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82

Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry (2003) 2.77

Assessing mobility in older adults: the UAB Study of Aging Life-Space Assessment. Phys Ther (2005) 2.76

Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2006) 2.73

Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol (2008) 2.68

Contribution of Alzheimer disease to mortality in the United States. Neurology (2014) 2.67

Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clin Transl Sci (2009) 2.60

Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol (2003) 2.56

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51

Cognitive impairment in chronic kidney disease. J Am Geriatr Soc (2004) 2.50

Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49

Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol (2005) 2.49

Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol (2011) 2.46

High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Arch Gen Psychiatry (2010) 2.43

Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol (2002) 2.43

Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 2.43

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation (2006) 2.42

Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology (2005) 2.39

The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35

Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol (2006) 2.32

High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Arch Intern Med (2006) 2.32

Depression and risk of developing dementia. Nat Rev Neurol (2011) 2.31

Adverse oral health and cognitive decline: the health, aging and body composition study. J Am Geriatr Soc (2013) 2.27

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25

Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res (2007) 2.19

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transplant (2009) 2.17

Promising strategies for the prevention of dementia. Arch Neurol (2009) 2.14

The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum (2008) 2.13

ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology (2007) 2.09

Survival advantage of black patients with kidney disease after acute myocardial infarction. Clin J Am Soc Nephrol (2006) 2.08

ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology (2014) 2.08

Activity energy expenditure and incident cognitive impairment in older adults. Arch Intern Med (2011) 2.07

Limited literacy in older people and disparities in health and healthcare access. J Am Geriatr Soc (2006) 2.06

The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med (2013) 2.05

Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int (2003) 2.04

Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem (2009) 2.03

Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02

Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension (2003) 1.99

Acute kidney injury and mortality in hospitalized patients. Am J Nephrol (2012) 1.99

Neighborhood poverty and racial differences in ESRD incidence. J Am Soc Nephrol (2007) 1.98

Executive function, more than global cognition, predicts functional decline and mortality in elderly women. J Gerontol A Biol Sci Med Sci (2007) 1.97

Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD. Am J Nephrol (2011) 1.96